These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 24900193)

  • 21. Initial Optimization of a New Series of γ-Secretase Modulators Derived from a Triterpene Glycoside.
    Fuller NO; Hubbs JL; Austin WF; Creaser SP; McKee TD; Loureiro RM; Tate B; Xia W; Ives JL; Findeis MA; Bronk BS
    ACS Med Chem Lett; 2012 Nov; 3(11):908-13. PubMed ID: 24900406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of SPI-1865, a novel gamma-secretase modulator, in multiple rodent models.
    Loureiro RM; Dumin JA; McKee TD; Austin WF; Fuller NO; Hubbs JL; Shen R; Jonker J; Ives J; Bronk BS; Tate B
    Alzheimers Res Ther; 2013; 5(2):19. PubMed ID: 23597079
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design of Pyridopyrazine-1,6-dione γ-Secretase Modulators that Align Potency, MDR Efflux Ratio, and Metabolic Stability.
    Pettersson M; Johnson DS; Humphrey JM; Butler TW; Am Ende CW; Fish BA; Green ME; Kauffman GW; Mullins PB; O'Donnell CJ; Stepan AF; Stiff CM; Subramanyam C; Tran TP; Vetelino BC; Yang E; Xie L; Bales KR; Pustilnik LR; Steyn SJ; Wood KM; Verhoest PR
    ACS Med Chem Lett; 2015 May; 6(5):596-601. PubMed ID: 26005540
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discovery of cyclopropyl chromane-derived pyridopyrazine-1,6-dione γ-secretase modulators with robust central efficacy.
    Pettersson M; Johnson DS; Rankic DA; Kauffman GW; Am Ende CW; Butler TW; Boscoe B; Evrard E; Helal CJ; Humphrey JM; Stepan AF; Stiff CM; Yang E; Xie L; Bales KR; Hajos-Korcsok E; Jenkinson S; Pettersen B; Pustilnik LR; Ramirez DS; Steyn SJ; Wood KM; Verhoest PR
    Medchemcomm; 2017 Apr; 8(4):730-743. PubMed ID: 30108792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Discovery of RO7185876, a Highly Potent γ-Secretase Modulator (GSM) as a Potential Treatment for Alzheimer's Disease.
    Ratni H; Alker A; Bartels B; Bissantz C; Chen W; Gerlach I; Limberg A; Lu M; Neidhart W; Pichereau S; Reutlinger M; Rodriguez-Sarmiento RM; Jakob-Roetne R; Schmitt G; Zhang E; Baumann K
    ACS Med Chem Lett; 2020 Jun; 11(6):1257-1268. PubMed ID: 32551009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of novel 5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine derivatives as γ-secretase modulators (Part 2).
    Takai T; Koike T; Nakamura M; Kajita Y; Yamashita T; Taya N; Tsukamoto T; Watanabe T; Murakami K; Igari T; Kamata M
    Bioorg Med Chem; 2016 Jul; 24(14):3192-206. PubMed ID: 27255179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery of indole-derived pyridopyrazine-1,6-dione γ-secretase modulators that target presenilin.
    Pettersson M; Johnson DS; Humphrey JM; Am Ende CW; Evrard E; Efremov I; Kauffman GW; Stepan AF; Stiff CM; Xie L; Bales KR; Hajos-Korcsok E; Murrey HE; Pustilnik LR; Steyn SJ; Wood KM; Verhoest PR
    Bioorg Med Chem Lett; 2015 Feb; 25(4):908-13. PubMed ID: 25582600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discovery of novel triazolobenzazepinones as γ-secretase modulators with central Aβ42 lowering in rodents and rhesus monkeys.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Shah S; Hayashi I; Hughes BL; Moxham CM; Bays NW; Smotrov N; Hill AD; Pan BS; Wu Z; Moy LY; Tanga F; Kenific C; Cruz JC; Walker D; Bouthillette M; Nikov GN; Deshmukh SV; Jeliazkova-Mecheva VV; Diaz D; Michener MS; Cook JJ; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3488-94. PubMed ID: 26212776
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis, and biological evaluation of a novel class of gamma-secretase modulators with PPARgamma activity.
    Hieke M; Ness J; Steri R; Dittrich M; Greiner C; Werz O; Baumann K; Schubert-Zsilavecz M; Weggen S; Zettl H
    J Med Chem; 2010 Jun; 53(12):4691-700. PubMed ID: 20503989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological and Toxicological Properties of the Potent Oral
    Wagner SL; Rynearson KD; Duddy SK; Zhang C; Nguyen PD; Becker A; Vo U; Masliah D; Monte L; Klee JB; Echmalian CM; Xia W; Quinti L; Johnson G; Lin JH; Kim DY; Mobley WC; Rissman RA; Tanzi RE
    J Pharmacol Exp Ther; 2017 Jul; 362(1):31-44. PubMed ID: 28416568
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of γ-secretase modulators with a novel activity profile by text-based virtual screening.
    Zettl H; Ness J; Hähnke V; Beher D; Jumpertz T; Saric A; Baumann K; Pietrzik CU; Bulic B; Schneider G; Weggen S
    ACS Chem Biol; 2012 Sep; 7(9):1488-95. PubMed ID: 22725102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological properties of a novel and potent γ-secretase modulator as a therapeutic option for the treatment of Alzheimer's disease.
    Murakami K; Watanabe T; Koike T; Kamata M; Igari T; Kondo S
    Brain Res; 2016 Feb; 1633():73-86. PubMed ID: 26707977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insensitivity to Abeta42-lowering nonsteroidal anti-inflammatory drugs and gamma-secretase inhibitors is common among aggressive presenilin-1 mutations.
    Czirr E; Leuchtenberger S; Dorner-Ciossek C; Schneider A; Jucker M; Koo EH; Pietrzik CU; Baumann K; Weggen S
    J Biol Chem; 2007 Aug; 282(34):24504-13. PubMed ID: 17573346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Iminoheterocycles as gamma-secretase modulators.
    Caldwell JP; Bennett CE; McCracken TM; Mazzola RD; Bara T; Buevich A; Burnett DA; Chu I; Cohen-Williams M; Josein H; Hyde L; Lee J; McKittrick B; Song L; Terracina G; Voigt J; Zhang L; Zhu Z
    Bioorg Med Chem Lett; 2010 Sep; 20(18):5380-4. PubMed ID: 20724152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chronic treatment with a novel γ-secretase modulator, JNJ-40418677, inhibits amyloid plaque formation in a mouse model of Alzheimer's disease.
    Van Broeck B; Chen JM; Tréton G; Desmidt M; Hopf C; Ramsden N; Karran E; Mercken M; Rowley A
    Br J Pharmacol; 2011 May; 163(2):375-89. PubMed ID: 21232036
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discovery of fused 5,6-bicyclic heterocycles as γ-secretase modulators.
    Qin J; Dhondi P; Huang X; Mandal M; Zhao Z; Pissarnitski D; Zhou W; Aslanian R; Zhu Z; Greenlee W; Clader J; Zhang L; Cohen-Williams M; Jones N; Hyde L; Palani A
    Bioorg Med Chem Lett; 2011 Jan; 21(2):664-9. PubMed ID: 21195610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triazoles as γ-secretase modulators.
    Fischer C; Zultanski SL; Zhou H; Methot JL; Brown WC; Mampreian DM; Schell AJ; Shah S; Nuthall H; Hughes BL; Smotrov N; Kenific CM; Cruz JC; Walker D; Bouthillette M; Nikov GN; Savage DF; Jeliazkova-Mecheva VV; Diaz D; Szewczak AA; Bays N; Middleton RE; Munoz B; Shearman MS
    Bioorg Med Chem Lett; 2011 Jul; 21(13):4083-7. PubMed ID: 21616665
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies to investigate the in vivo therapeutic window of the gamma-secretase inhibitor N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide (LY411,575) in the CRND8 mouse.
    Hyde LA; McHugh NA; Chen J; Zhang Q; Manfra D; Nomeir AA; Josien H; Bara T; Clader JW; Zhang L; Parker EM; Higgins GA
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1133-43. PubMed ID: 16946102
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer's Disease.
    Bulic B; Ness J; Hahn S; Rennhack A; Jumpertz T; Weggen S
    Curr Neuropharmacol; 2011 Dec; 9(4):598-622. PubMed ID: 22798753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes.
    Imbimbo BP; Giardina GA
    Curr Top Med Chem; 2011; 11(12):1555-70. PubMed ID: 21510832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.